Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000183499 | SCV000235959 | uncertain significance | not provided | 2024-03-07 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Fulgent Genetics, |
RCV000765352 | SCV000896617 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000765352 | SCV001536486 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-11-18 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 452 of the JUP protein (p.Thr452Ser). This variant is present in population databases (rs794729045, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 201823). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV003165403 | SCV003911928 | uncertain significance | Cardiovascular phenotype | 2023-01-07 | criteria provided, single submitter | clinical testing | The p.T452S variant (also known as c.1354A>T), located in coding exon 7 of the JUP gene, results from an A to T substitution at nucleotide position 1354. The threonine at codon 452 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |